Literature DB >> 34061234

Female sexuality before and after sacrocolpopexy or vaginal mesh: is vaginal length one of the key factors?

Sònia Anglès-Acedo1, Cristina Ros-Cerro2, Sílvia Escura-Sancho1, M José Palau-Pascual1, Eduardo Bataller-Sánchez1, Montserrat Espuña-Pons1, Francisco Carmona-Herrera1.   

Abstract

INTRODUCTION AND HYPOTHESIS: We aimed to demonstrate that laparoscopic sacrocolpopexy/cervicopexy (LSC-Cx) versus anterior vaginal mesh (AVM) results in a longer vaginal length without impacting sexual activity or function.
METHODS: We performed a secondary analysis of sexual outcomes of a previous randomized control trial comparing LSC-Cx and AVM in 120 women (60/group) with symptomatic POP stage ≥ 3. We evaluated sexually active (SA) and non-sexually active women (NSA) using the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA-Revised (PISQ-IR) preoperatively and 1 year postoperatively. Multivariate logistic and linear regression models were built to assess the impact of different variables on sexual activity and function, respectively.
RESULTS: Among 120 women included, no statistically significant differences were found between vaginal length and preoperative dyspareunia (20.7% AVM vs. 22,8% LSC-Cx) comparing SA to NSA women and LSC-Cx to AVM. Vaginal length was significantly longer after LSC-Cx versus AVM (p < 0.001). The postoperative dyspareunia rate was 17.2% AVM versus 10.5% LSC-Cx. Partnered women were significantly more likely to be SA than unpartnered women before (OR = 19.04; p = 0.006) and after surgery (OR = 36.28; p = 0.002). Only dyspareunia was independently associated with sexual function pre- (B = -0.431; p = 0.017) and postoperatively (B = -0.3 96; p = 0.007).
CONCLUSIONS: Vaginal length was greater following LSC-Cx compared to AVM. While vaginal length has no impact on female sexuality pre- and postoperatively, the most important factors were "having a partner" for sexual activity and dyspareunia for sexual function. Persistence of dyspareunia was higher after AVM. LSC-Cx should be considered in women with POP undergoing mesh surgery with future sexual expectations.
© 2021. The International Urogynecological Association.

Entities:  

Keywords:  Anterior vaginal mesh; Laparoscopic sacrocolpopexy/cervicopexy; Pelvic organ prolapse; Sexual activity; Sexual function; Vaginal length

Mesh:

Year:  2021        PMID: 34061234     DOI: 10.1007/s00192-021-04697-y

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  11 in total

1.  Spanish version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire IUGA-Revised (PISQ-IR): Transcultural validation.

Authors:  Montserrat Mestre; Judith Lleberia; Josep Pubill; Montserrat Espuña-Pons
Journal:  Int Urogynecol J       Date:  2017-04-08       Impact factor: 2.894

2.  Validation of a single summary score for the Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR).

Authors:  Melissa L Constantine; Rachel N Pauls; Rebecca R Rogers; Todd H Rockwood
Journal:  Int Urogynecol J       Date:  2017-06-06       Impact factor: 2.894

3.  Body image in women before and after reconstructive surgery for pelvic organ prolapse.

Authors:  Jerry L Lowder; Chiara Ghetti; Pamela Moalli; Halina Zyczynski; Thomas F Cash
Journal:  Int Urogynecol J       Date:  2010-05-04       Impact factor: 2.894

4.  Changes in Sexual Activity and Function After Pelvic Organ Prolapse Surgery: A Systematic Review.

Authors:  Danielle D Antosh; Shunaha Kim-Fine; Kate V Meriwether; Gregg Kanter; Alexis A Dieter; Mamta M Mamik; Meadow Good; Ruchira Singh; Alexandriah Alas; Mohamed A Foda; Ethan M Balk; David D Rahn; Rebecca G Rogers
Journal:  Obstet Gynecol       Date:  2020-11       Impact factor: 7.661

5.  Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT).

Authors:  Cathryn Ma Glazener; Suzanne Breeman; Andrew Elders; Christine Hemming; Kevin G Cooper; Robert M Freeman; Anthony Rb Smith; Fiona Reid; Suzanne Hagen; Isobel Montgomery; Mary Kilonzo; Dwayne Boyers; Alison McDonald; Gladys McPherson; Graeme MacLennan; John Norrie
Journal:  Lancet       Date:  2016-12-21       Impact factor: 79.321

6.  Anatomical outcomes 1 year after pelvic organ prolapse surgery in patients with and without a uterus at a high risk of recurrence: a randomised controlled trial comparing laparoscopic sacrocolpopexy/cervicopexy and anterior vaginal mesh.

Authors:  Eduardo Bataller; Cristina Ros; Sonia Anglès; Miriam Gallego; Montserrat Espuña-Pons; Francisco Carmona
Journal:  Int Urogynecol J       Date:  2018-07-09       Impact factor: 2.894

7.  Do external female genital measurements affect genital perception and sexual function and orgasm?

Authors:  Aşkı Ellibeş Kaya; Ozan Doğan; Murat Yassa; Alper Başbuğ; Canan Özcan; Eray Çalışkan
Journal:  Turk J Obstet Gynecol       Date:  2020-10-02

8.  Conceptual framework for patient-important treatment outcomes for pelvic organ prolapse.

Authors:  Vivian W Sung; Rebecca G Rogers; Matthew D Barber; Melissa A Clark
Journal:  Neurourol Urodyn       Date:  2013-03-13       Impact factor: 2.696

9.  Safety of Vaginal Mesh Surgery Versus Laparoscopic Mesh Sacropexy for Cystocele Repair: Results of the Prosthetic Pelvic Floor Repair Randomized Controlled Trial.

Authors:  Jean-Philippe Lucot; Michel Cosson; Georges Bader; Philippe Debodinance; Cherif Akladios; Delphine Salet-Lizée; Patrick Delporte; Denis Savary; Philippe Ferry; Xavier Deffieux; Sandrine Campagne-Loiseau; Renaud de Tayrac; Sébastien Blanc; Sandrine Fournet; Arnaud Wattiez; Richard Villet; Marion Ravit; Bernard Jacquetin; Xavier Fritel; Arnaud Fauconnier
Journal:  Eur Urol       Date:  2018-02-19       Impact factor: 20.096

10.  Immediate Postoperative Pelvic Organ Prolapse Quantification Measures and 2-Year Risk of Prolapse Recurrence.

Authors:  Lauren N Siff; Matthew D Barber; Halina M Zyczynski; Charles R Rardin; Sharon Jakus-Waldman; David D Rahn; Ariana L Smith; Donna Mazloomdoost; Amaanti Sridhar; Marie G Gantz
Journal:  Obstet Gynecol       Date:  2020-10       Impact factor: 7.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.